HuGE Literature Finder
Records
1
-
20
| Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing. International journal of molecular sciences 2022 Oct 23 (19): . Hattinger Claudia Maria, Casotti Chiara, Patrizio Maria Pia, Luppi Silvia, Fantoni Leonardo, Scotlandi Katia, Ibrahim Toni, Serra Massi |
| Association of ERCC gene polymorphism with osteosarcoma risk. African health sciences 2020 Dec 20 (4): 1840-1848. Wang Guanliang, Li Jianping, Xu Xiling, Gupta Ramit Kumar, Gao Xiaoqia |
| Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population. Medicine 2018 Dec 97 (49): e13358. Liu Dabiao, Liu Xueso |
| ERCC polymorphisms and risk of osteosarcoma: a meta-analysis. European review for medical and pharmacological sciences 2018 Oct 22 (20): 6658-6666. Chen X-J, Tong Z-C, Kang X, Wang Z-C, Huang G-L, Yang T-M, Dong |
| The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients. BMC medical genetics 2018 Jul 19 (1): 112. Obiedat Hadeel, Alrabadi Nasr, Sultan Eyad, Al Shatti Marwa, Zihlif Mal |
| Association between common polymorphisms in ERCC gene and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis. OncoTargets and therapy 2018 11 3495-3504. Li Chunpu, Yu Xin, Guo Dongmei, Liu Guanhua, Zhang Kaigang, Teng Qingliang, Lin H |
| Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis. Oncotarget 2017 Sep 8 (37): 62769-62779. Liu Xueyong, Zhang Zhan, Deng Chunbo, Tian Yihao, Ma X |
| Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis. World journal of surgical oncology 2017 Apr 15 (1): 75. Zhang Haiguang, Ge Junbo, Hong Huanyu, Bi Lili, Sun Zhengw |
| Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer. Oncology letters 2015 Apr 9 (4): 1657-1661. Gómez-Díaz Benjamín, DE LA Luz Ayala-Madrigal María, Gutiérrez-Angulo Melva, Valle-Solis Aura Erazo, Linares-González Luis Miguel, González-Guzmán Roberto, Cruz-Guillén David, Cedeño-Garcidueñas Ana Lilia, Canto Patricia, López-Hernández Luz Bereni |
| Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma. Cancer epidemiology 2015 Apr 39 (2): 182-8. Gori?ar Katja, Kova? Viljem, Jazbec Janez, Zakotnik Branko, Lamovec Janez, Dolžan Vi |
| Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma. Genetics and molecular research : GMR 2015 14 (3): 10145-51. Cao Z H, Yin H P, Jiang N, Yu |
| Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma. International journal of clinical and experimental pathology 2015 8 (7): 7905-12. Sun Yongjian, Wu Yi, Li Weicheng, Kong Zhen, Zou Xiaomi |
| Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma. Genetics and molecular research : GMR 2015 14 (3): 11652-7. Wang M J, Zhu Y, Guo X J, Tian Z |
| Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma. Genetics and molecular research : GMR 2015 14 (3): 11235-41. Zhang Q, Lv L Y, Li B J, Zhang J, Wei |
| Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma. International journal of clinical and experimental pathology 2015 8 (1): 894-9. Ji Wei-Ping, He Neng-B |
| ERCC polymorphisms and prognosis of patients with osteosarcoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Oct 35 (10): 10129-36. Li Jinsong, Liu Shaohua, Wang Weiguo, Zhang Kexiang, Liu Zhendong, Zhang Chaoyue, Chen Shijie, Wu So |
| Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients. Asian Pacific journal of cancer prevention : APJCP 2012 13 (8): 3821-4. Hao Ting, Feng Wei, Zhang Jie, Sun Yong-Jian, Wang Ga |
| Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors. Asian Pacific journal of cancer prevention : APJCP 2012 13 (11): 5883-6. Yang Li-Min, Li Xiu-Hua, Bao Cui-F |
| Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. The pharmacogenomics journal 2009 Oct 9 (5): 347-53. Caronia D, Patiño-García A, Milne R L, Zalacain-Díez M, Pita G, Alonso M R, Moreno L T, Sierrasesumaga-Ariznabarreta L, Benítez J, González-Neira |
| Single nucleotide polymorphisms of nucleotide excision repair and homologous recombination repair pathways and their role in the risk of osteosarcoma. Pakistan journal of medical sciences 0 31 (2): 269-73. Jin Guojun, Wang Min, Chen Weida, Shi Wei, Yin Jiapeng, Gang Wa |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: